[Sources of Support] ABSTRACT Urinary (u) neutrophil gelatinase-associated lipocalin (Ngal or lipocalin 2) is a very early and sensitive biomarker for kidney injury but its source and time course during treatment remain elusive. In the present study we show that uNgal concentrations were markedly elevated in A-ZIP/F-1 lipoatrophic diabetes and streptozotocin-induced diabetic (STZ) mice. In STZ mice, reabsorption of Ngal in the proximal tubule was severely reduced but upregulation of Ngal mRNA and protein expression in the kidney was little compared to non-diabetic control mice, indicating that increased uNgal excretion derived mainly from impaired renal reabsorption. In mouse kidneys treated with unilateral ureteral obstruction, Ngal protein was highly accumulated in thick ascending limbs of Henle and in the urine pooled in pelvis. In 5 patients with nephrotic syndrome or interstitial nephritis, uNgal levels were elevated markedly, and were decreased in response to treatment including steroids. Treatment of STZ mice with angiotensin receptor blocker candesartan dramatically reduced uNgal excretion. These findings indicate that uNgal level is a unique biomarker of renal injury incorporating information of glomerular filtration defect, tubular reabsorption dysfunction and distal nephron damage, and may be useful in monitoring disease activity and treatment efficacy in various forms of renal injury.
INTRODUCTION
Neutrophil gelatinase-associated lipocalin (Ngal) is a differentiation inducer for epithelia in embryonic kidney, whose expression is dramatically increased in acute kidney injury (AKI). [1] [2] [3] [4] [5] Ngal exerts a spectrum of iron-dependent biological activities, [1] [2] [3] [4] 6 and administration of Ngal protein mitigates renal injury in mice, suggesting that functional consequence of Ngal upregulation is renoprotection. 2 Ngal mRNA levels in the kidney are increased as much as by 1000-fold during renal ischemia-reperfusion injury in mice. 2, 7 Ngal protein starts to accumulate within a few hours in the blood and urine during AKI. [8] [9] [10] [11] These characteristics of Ngal have made it a promising biomarker of AKI that is found in the blood and urine. 1, 7, [12] [13] [14] [15] Furthermore, several studies reported that serum and urinary Ngal levels are elevated proportionally to the extent of renal damage in chronic kidney disease (CKD), 16, 17 but the source and the time course of urinary Ngal concentrations are largely unknown. In this study, we investigated urinary Ngal levels in four types of renal damage caused by distinct mechanism: nephrotic syndrome caused by glomerular disorders, diabetic nephropathy, obstructive nephropathy and interstitial nephritis. We also examined whether measurement of urinary Ngal is useful for the monitoring of renal damage in mice or humans during the treatment course.
RESULTS

Urinary Ngal excretion is proportional to albumin excretion in mouse models of diabetic nephropathy
As a model of diabetic nephropathy, we first examined urinary Ngal concentrations in A-ZIP/F-1 transgenic mice, which are characterized with lipoatrophic diabetes, fatty liver, hyperlipidemia, severe insulin resistance and massive proteinuria. [18] [19] [20] Urinary Ngal excretion in A-ZIP/F-1 mice at 10 months of age was much larger than that in control FVB/N mice (Figure 1 ). By Western blot, we observed 30 and 25 kDa bands with Ngal immunoreactivity, and the larger band was found only in the urine from A-ZIP/F-1 mice and not in the urine or tissues from normal, diabetic or obstructed kidneys of mice with C57BL/6 background (see below). The larger protein may have heavier glycosylation than the smaller protein. 21 When the amounts of two proteins were added, mice with larger urinary Ngal levels tended to have larger urinary albumin levels.
Next, we studied streptozotocin (STZ)-induced diabetes, which manifests with insulin deficiency and microalbuminuria. In STZ mice, urinary albumin excretion increased gradually and, after 8 weeks, reached 7.8-fold of the level before STZ injection ( Figure 2 ). On the other hand, urinary Ngal levels were elevated by 77-fold at 8 weeks.
The extent of Ngal and albumin excretion was highly variable among different mice, but urinary albumin levels and log transformation of Ngal levels showed a close linear correlation throughout the course of 12 week observation period.
Elevation of urinary Ngal excretion in STZ mice is not caused by renal synthesis but by reabsorption defect, and treatment with angiotensin receptor blocker reduces urinary Ngal levels
To examine whether local expression of Ngal is increased in STZ mouse kidneys, we studied expression levels of Ngal protein in the whole kidney preparation of STZ and non-STZ control mice and found no significant difference at 8 weeks after STZ treatment ( Figure 3 ). We did not find significant alteration of Ngal protein expression in the livers, either. Of note, serum Ngal levels in STZ mice were significantly lower than those in non-STZ mice (23±5 versus 111±22 ng ml -1 , n=3-4, P<0.01). We measured Ngal mRNA expression levels in the kidneys and livers of STZ mice, but they were increased only marginally compared to control mice. As a positive control, Ngal mRNA expression was increased by 100 fold in obstructed kidneys after 1 day of ureter ligation (P<0.001).
These findings suggested that dramatic (nearly 80 fold) increase of urinary Ngal excretion in STZ mice cannot be explained by augmentation of Ngal protein synthesis in the kidney, and led us to investigate tubular reabsorption of Ngal. Injection of histidine-tagged or Alexa Fluor 546-labeled Ngal (21 kDa in size) in the peritoneum of non-STZ mice resulted in glomerular filtration and efficient reabsorption of Ngal at the proximal tubules from the apical side, thus no exogenous Ngal was detected in the urine ( Figure 4 ). In STZ mice, on the other hand, substantial amount of exogenous Ngal was excreted in the urine and reabsorption of labeled Ngal was reduced by 47 % (P<0.01).
Since treatment of diabetic nephropathy with angiotensin receptor blocker (ARB) reduces proteinuria and ameliorates renal injury, 22 we gave the ARB candesartan to STZ mice through drinking water at 10 mg per kg per day ( Figure 5 ). After one week, urinary albumin levels were decreased by 14 % (P<0.05) and urinary Ngal levels were decreased by 77 % (P<0.05). Serum Ngal levels were not altered by candesartan (20±6 ng ml -1 ). The dose of candesartan used was a subdepressor dose, and did not significantly affect body weights, blood glucose, urea nitrogen and creatinine levels ( Table 1) . Through these findings, we conclude that increased urinary Ngal excretion in STZ mice was caused mainly by reabsorption defect and treatment with candesartan partially normalized urinary Ngal levels.
Urinary Ngal levels are highly elevated in human cases of nephrotic syndrome and are decreased in response to treatment
As cases of glomerular disorders with nephrotic syndrome, we investigated the clinical courses and changes in serum and urinary Ngal levels in human subjects. Case 1 was a 68-year-old female with biopsy-proven minimal change disease. She had nephrotic range proteinuria (14 g day -1 ) and gained body weight by 15 kg (from 62 to 77 kg) within 3 weeks. She was treated with iv steroid pulse (methyl prednisolone 1 g x 3 days), followed with oral prednisolone (beginning with 35 mg per day), and with three courses of hemodialysis on days 8, 9 and 12 after admission ( Figure 6 ). Her proteinuria, edema and azotemia resolved gradually. Concomitantly, urinary and serum Ngal levels decreased during the treatment, but reduction was much faster for urinary Ngal levels.
There was a temporal elevation of urinary Ngal levels on day 21, which might reflect the reappearance of oligouria or proteinuria. Case 2 was a 26-year-old female, who was diagnosed to have membranous-type lupus nephritis (ISN/RPS class V). She was treated with two courses of iv steroid pulse, followed with oral prednisolone ( Figure 6 ). Her urinary levels of protein and Ngal were decreased sharply within 17 days.
Case 3 was a 55-year-old female with clinically-diagnosed lupus nephritis (no biopsy). She had been treated with two courses of iv steroid pulse (1 g x 3 days) and oral prednisolone had been tapered from 50 to 35 mg per day, before changing the hospitals to ours. She was given iv cyclophosphamide pulse (0.4 g, once, 6 days after admission) and the immunosuppressant mizoribine (Asahi Kasei Pharma, Osaka, Japan; 100 mg per day). Urinary excretion of protein and Ngal decreased slowly (Supplementary Figure S1 ). Serum creatinine levels were constant throughout the course (0.4-0.5 mg per 100 ml).
Case 4 was a 69-year-old male, who suffered from rapidly-progressing, crescentic glomerulonephritis accompanied with moderate tubulointerstitial damage.
His serum contained myeloperoxidase-type anti-neutrophil cytoplasmic antibody (MPO-ANCA, 138 EU). The maximum serum creatinine level was 5.6 mg per 100 ml, and the proteinuria and azotemia responded slowly to treatment containing oral and iv steroid and iv cyclophosphamide (Supplementary Figure S1 ). Macrohematuria was observed, peaking at 5 days after cyclophosphamide administration. After 10 months, he showed signs of recurrence which were worsening in proteinuria, hematuria, azotemia and MPO-ANCA titer (from <10 to 37 EU). We observed re-elevation of urinary Ngal levels during acute worsening of nephritis. Cyclosporine A (75 mg day -1 before breakfast) was added at 13 months, which appeared to support reduction of above mentioned signs.
To understand renal localization of Ngal protein in nephrotic patients, we (Figure 7 , Supplementary Figures S2-S4 ). In the UUO kidneys, after 1 day of ureter ligation, Ngal protein was expressed exclusively in thick ascending limbs of Henle, which was also expressing THP and was prominently dilated, suggesting that Ngal was synthesized in damaged epithelia. By striking contrast, in the contra-lateral kidneys, Ngal protein was confined to the apical side of aquaporin 1 + proximal tubules. Ngal protein levels in the obstructed kidneys and in the urine from the dilated pelvis were continuously elevated for 2 weeks, whereas those in the non-obstructed kidneys and in the serum peaked at day 1 and decreased gradually. A smaller (17 kDa) fragment detected in the kidneys (but not in the urine and serum) using polyclonal anti-Ngal antibody may have been generated by lysosomal proteolysis of Ngal in the tubules. 2 Ngal mRNA expression was elevated by 100-fold in the obstructed kidneys ( Figure 3 ), but it was only elevated by 3-fold in the contra-lateral kidneys at day 1 (data not shown). These findings indicate that Ngal was synthesized de novo in distal nephrons of obstructed kidneys, while it was highly but transiently Manuscript ID: KI-04-08-0564.R1
Source and changes of urinary Ngal in renal injury accumulated in the serum, filtrated and reabsorbed in the contra-lateral kidneys.
In a case with interstitial nephritis, urinary Ngal levels decreased more rapidly than classic markers of tubular injury.
Next, we investigated whether urinary Ngal is useful for evaluation of renal disorder with low level proteinuria. Case 5 was a 25-year-old male, who was admitted to our hospital, presenting with general malaise, proteinuria (0.4 g day -1 ), renal glucosuria and mild azotemia. He had taken an over-the-counter cold medicine 6 weeks earlier, and was positive in lymphocyte stimulation test for the drug. Renal biopsy revealed subacute interstitial nephritis with minor glomerular lesions. His signs and symptoms resolved by oral and iv prednisolone treatment. Table 2 and Supplementary Figure S5 
DISCUSSION
In the present study, we investigated urinary Ngal concentrations in patients with nephrotic syndrome (caused by acute and severe glomerular disorders) and interstitial nephritis and in mouse models of diabetic or obstructive nephropathy and found that the levels were unequivocally elevated (over 10 fold of control). Ngal may be useful in the monitoring of disease activity and treatment efficacy. Of note, we cannot over-generalize the findings in this study to all renal disorders, especially because we did not examine patients with severe, acute tubular necrosis, for instance, caused by renal ischemia or nephrotoxins (in which Ngal is abundantly synthesized by renal epithelia). 2 In diabetic nephropathy, albumin excretion is increased by leakage from glomerular filtration barrier. 24 On the other hand, a number of reports elucidated the involvement of tubular dysfunction as a cause of albuminuria. [24] [25] [26] [27] The size of Ngal protein (25 kDa) is smaller than albumin and, in normal conditions, Ngal is rapidly filtered by glomeruli and reabsorbed very efficiently by proximal tubules, leaving only 0.1-0.2% in the urine. 2 By analyzing renal handling of exogenously injected Ngal, the present study emphasized the existence of tubular reabsorption impairment in diabetic nephropathy. 28 In reverse, cellular stress in the proximal tubules may cause deterioration in diabetic nephropathy, since it was reported that transgenic overexpression of catalase in the proximal tubules of mice attenuated development of hypertension and albuminuria associating diabetic nephropathy. 29 Treatment of STZ-diabetic mice with ARB significantly reduced urinary excretion of both Ngal and albumin. Two major scenarios can be proposed. First, ARB directly improved reabsorption efficiency in the proximal tubules, which may be mediated by increased peritubular capillary blood flow 30 and by amelioration of oxidative stress. 31 Second, ARB reduced intraglomerular hypertension and hyperfiltration, 32 reduced albumin leakage from glomeruli, and the total amount of the ligands for the common scavenger receptor megalin was decreased in the tubular lumen.
This may increase the ratio of Ngal and albumin endocytosed at proximal tubules.
Here we used high-dose STZ to induce a model of diabetic nephropathy. Direct toxicity of STZ to proximal tubules may have exaggerated the elevation of urinary Ngal levels in these mice (which is 77-fold of control mice). 33 Hyperfiltration is reported in rodents given STZ. 32 In a previous report, 3-fold elevation in creatinine clearance was observed in C57BL/6 mice after treatment with STZ, but serum creatinine levels were not significantly decreased, likely due to concomitant osmotic diuresis and dehydration. 34 In the present study, hyperfiltration may have similarly occurred in STZ-diabetic mice. Growth arrest and leanness of STZ-diabetic mice may be partly related to selective reduction of serum Ngal levels (but not serum creatinine and BUN levels) in the present study, since obesity has been shown to be associated with elevated circulating Ngal levels. 35 We also observed abundant urinary Ngal excretion in 4 patients with nephrotic syndrome. The mechanism may involve direct competition between Ngal and albumin at the surface of megalin molecule for receptor-mediated endocytosis 26, 36 and also general malfunctioning of proximal tubules because of protein overload. Furthermore, a fraction of urinary Ngal may originate from renal synthesis in addition to reabsorption defect, but Ngal gene expression in human samples was not investigated in this study.
The time required for urinary Ngal reduction was variable among cases: ranging from 2 weeks (cases 1 and 2) to more than a month (cases 3 and 4).
In a case with interstitial nephritis, urinary Ngal showed the largest fold increase and the quickest response to steroid treatment in comparison to other urinary biomarkers: total protein, α1and β2-microglobulins and NAG. These findings suggest that urinary Ngal might be particularly useful in the evaluation of kidney recovery in patients with low grade proteinuria.
To summarize, urinary Ngal is a rapid biomarker of kidney injury and recovery
showing a large fold-increase or decrease during clinical course of various renal disorders. Proteinuria seems to be one of important factors affecting Ngal'uria.
MATERIALS AND METHODS
Animal experiments
All animal experiments were conducted in accordance with our institutional guidelines for animal research. Male A-ZIP/F-1 heterozygous transgenic mice and control FVB/N littermates were used at 10 month of age, when A-ZIP/F-1 mice exhibit diabetic nephropathy with massive proteinuria. [18] [19] [20] Other animal experiments were carried out with male C57BL/6J mice (Japan Clea, Tokyo, Japan) starting at 8 week of age, when were assayed by the enzymatic method (SRL, Tokyo, Japan). This method gives reliable measurement when compared to high-performance liquid chromatography method, even in low concentration materials, and performs much better than Jaffe's colorimetric method. 37 Blood glucose and HbA1c levels were determined in tail vein blood at ad libitum-fed conditions using Glutest Ace (Sanwa Kagaku, Nagoya, Japan) and DCA2000+ Analyzer (Bayer Medical, Tokyo, Japan), respectively. Mice were killed under pentobarbital anesthesia before organ collection. Prodrug of candesartan, candesartan cilexetil (TCV-116; Takeda Chemical Industries, Osaka, Japan), was initially dissolved at 10 mg ml -1 in a solution containing 16% polyethylene glycol #300 (vol/vol; Nacalai, Kyoto, Japan), 16% ethanol (Nacalai) and 0.7 M Na2CO3, and further diluted in drinking water to be given at a final dose of 10 mg per kg per day. This treatment method 38 gave less blood pressure lowering effects compared to gavage administration as previously described. 39 For UUO, mice were anesthetized with pentobarbital, the left kidney was exposed by midline incision, and the left ureter was ligated with 4-0 silk at two points. 40 Mice were sacrificed 1-14 days after the operation.
Recombinant Ngal injection and detection
To were normalized by GAPDH (internal control) levels, whose primer-probe set was purchased from Applied Biosystems. 41 Standard curve was made by serial dilution of cDNA from UUO kidneys.
Immunofluorescence of Ngal and albumin
Snap frozen human biopsy samples were sliced at 3 µm thickness, fixed with acetone, and incubated with a solution containing both FITC-labeled rabbit anti-human albumin antibody (Dako, Glostrup, Denmark) and goat polyclonal anti-human Ngal antibody (R&D Systems), followed by incubation with TexasRed-labeled anti-goat IgG (Jackson Immunoresearch, West Grove, PA, USA). The spillover of each signal was negligible.
Immunohistochemistry of Ngal and nephron markers
Mouse kidneys were fixed in 4% paraformaldehyde at 4oC for 12 hours and embedded in paraffin. Renal sections of 4 µm were deparaffined, hydrated and incubated with 0.3% hydrogen peroxide. Antigen retrieval was performed by 0.05 mol L -1 citrate buffer (pH 6.0) for 10min in a water bath heated at 100 oC (for Ngal, AQP1 and AQP2), or in a microwave oven (for THP). After cooling, the sections were incubated with 10% normal donkey or goat serum, followed by goat anti-mouse Ngal 
Statistical analysis
Results are expressed as mean±s.e. Student's t-test was carried out to compare two groups. Statistical significance was defined as P<0.05.
SUPPLEMENTARY MATERIALS
Figure S1
Clinical course of cases with (a) lupus nephritis (Case 3, LN) and (b) crescentic glomerulonephritis (Case 4, CrescGN).
Figure S2
Low power fields showing expression of Ngal and nephron markers in unilateral ureteral obstruction (UUO) and contra-lateral kidneys.
Figure S3
High power fields of cortex showing expression of Ngal and nephron markers in UUO and contra-lateral kidneys.
Figure S4
High power fields of medulla showing expression of Ngal and nephron markers in UUO and contra-lateral kidneys.
Figure S5
Clinical course of a case with drug-induced interstitial nephritis (Case 5, IntN). 
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